Submission Details
| 510(k) Number | K240693 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 13, 2024 |
| Decision Date | March 28, 2024 |
| Days to Decision | 15 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K240693 is an FDA 510(k) clearance for the LINQ II? Insertable Cardiac Monitor (ICM), a Recorder, Event, Implantable Cardiac, (with Arrhythmia Detection) (Class II — Special Controls, product code MXD), submitted by Medtronic, Inc. (Mounds View, US). The FDA issued a Cleared decision on March 28, 2024, 15 days after receiving the submission on March 13, 2024. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.1025.
| 510(k) Number | K240693 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 13, 2024 |
| Decision Date | March 28, 2024 |
| Days to Decision | 15 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | MXD — Recorder, Event, Implantable Cardiac, (with Arrhythmia Detection) |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.1025 |